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Purpose
Health economic studies gain more and more impor-
tance in both conventional and complementary medi-
cine. In most cases such studies are conducted as a
combination of a RCT and a health economic evaluation
(“Piggy-Back-Studies”). Therefore study planning para-
meters like sample size still are calculated on the basis
of the outcome of the clinical parameters. This might
lead to situations of underpowering.
Methods
Based on the sample size estimates given in Glick
(2011), we aimed at finding health economic studies of
CAM providing mean and standard deviation data on
cost and outcome differences. Based on this data and on
assumptions on willingness to pay and cost-outcome
correlation, we constructed a model of principally
achievable significance.
Results
Based on an existing review on health economic studies
in CAM, 8 of 143 studies mentioned sample size calcu-
lation parameters. However, only one study (Lin et al.
2008) provided enough data for modelling. We found a
significant discrepancy between the sample size of n=46
based on conventional sample size calculation and the
hypothetically needed patients of more than 350 based
on our modelling approach.
Conclusion
Planning health economic studies should be done with
great caution not to end in a situation of small power.
Our approach might retrospectively give estimates of
regions of significance and thus might help to interpret
health economic studies not only in the field of CAM.
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